Placebo-induced analgesia in an operant pain model in rats

College of Dentistry, Department of Orthodontics, University of Florida, Gainesville, FL, USA.
Pain (Impact Factor: 5.84). 08/2012; 153(10):2009-16. DOI: 10.1016/j.pain.2012.04.026
Source: PubMed

ABSTRACT Analgesia is particularly susceptible to placebo responses. Recent studies in humans have provided important insights into the neurobiology underlying placebo-induced analgesia. However, human studies provide incomplete mechanistic explanations of placebo analgesia because of limited capacity to use cellular, molecular, and genetic manipulations. To address this shortcoming, this article describes the development of a rat model of conditioned analgesia in an operant pain assay. Specifically, rats were conditioned to associate a placebo manipulation with the analgesic effect of 1mg/kg morphine (subcutaneously) on facial thermal pain. We found that conditioned (placebo) responding bore 3 of the hallmarks of placebo-induced analgesia: (1) strong interanimal variability in the response, (2) suppression by the opiate antagonist naloxone (5mg/kg subcutaneously), and (3) a positive predictive relationship between the unconditioned analgesic effect and the conditioned (placebo) effect. Because of the operant nature of the assay and the use of only a mild noxious thermal stimulus, we suggest that these results provide evidence of placebo-induced analgesia in a preclinical model that utilizes an affective behavioral end point. This finding may provide opportunities for invasive preclinical studies allowing greater understanding of placebo-induced analgesia, thus paving the way for avenues to harness its benefits.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ongoing efforts to improve clinical trial design in irritable bowel syndrome have been hindered by high placebo response rates and ineffective outcome measures. We assessed established strategies to minimize placebo effect as well as the various ap-proaches to placebo effect which can affect trial design. These include genetic markers such as catechol-O-methyltransferase, opioidergic and dopaminergic neurobiologic theory, pre-cebo effect centered on expectancy theory, and side effect unblinding grounded on conditioning theory. We reviewed endpoints used in the study of IBS over the past decade including adequate relief and subjective global relief, emphasizing their weaknesses in fully evaluating the IBS condition, specifically their motility effects based on functional net value and relative benefit-harm based on dropouts due to adverse events. The focus of this review is to highlight ongoing efforts to improve clinical trial design which can lead to better outcomes in a real-world setting.
    Journal of neurogastroenterology and motility 04/2014; 20(2):163-170. DOI:10.5056/jnm.2014.20.2.163 · 2.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: AimThe aim of this single-center, two-cell, double-blind, randomized controlled clinical study was to evaluate the effectiveness of an in-office desensitizing paste containing 8% arginine and calcium carbonate in providing relief on dentine hypersensitivity immediately after scaling and root planing and its sustained relief over a 6-week period.Materials and Methods Fifty periodontitis subjects presenting hypersensitivity were subjected to scaling and root planing and in-office application of either 8% arginine and calcium carbonate desensitizing paste (25 subjects, test group) or fluoride-free prophylaxis paste (25 subjects, control group). Air-blast hypersensitivity was assessed using Schiff and Visual Analog (VAS) scales at baseline, post-scaling, post-prophy, 2-, 4-, 6-weeks.ResultsAt all evaluation times, the test group presented significant % reduction in hypersensitivity relative to post-scaling (t-test, p < 0.05) (Schiff:Test: 57, 58.6, 60.2, 68, Control: 28.6, 22.2, 23, 23) (VAS: Test: 60, 55.6, 60.1, 68.4, Control: 25.9, 18.2, 20.6, 22.7) and significant % hypersensitivity difference relative to control (ANCOVA, p < 0.05) (Schiff: 38.9, 45.9, 47.4, 57.7, VAS: 49.1, 48.9, 52.6, 61).Conclusions The single in-office application of the 8% arginine-calcium carbonate desensitizing paste after scaling and root planing provided significant immediate reduction of dentine hypersensitivity, which sustained over a 6-week period.This article is protected by copyright. All rights reserved.
    Journal Of Clinical Periodontology 10/2014; 42(1). DOI:10.1111/jcpe.12319 · 3.61 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recent research on human placebo analgesia has suggested the need for rodent models in order to further elucidate the neural substrates of the placebo effect. This series of three experiments therefore attempted to develop a model of placebo analgesia in rats. In each study, female Sprague Dawley rats received an L5 spinal nerve ligation to induce a neuropathic pain condition. Each rat then underwent a four-day conditioning procedure in which an active analgesic drug or its vehicle (unconditioned stimulus) was associated with the following cues (conditioned stimuli): novel testing room (environmental), vanilla scent cue (olfactory), dim incandescent lighting (visual), restraint procedure/injection (tactile), time of day and injection-test latency (temporal). The analgesics for each experiment were as follows: Experiment 1 used 90 mg/kg gabapentin, Experiment 2 used 3 mg/kg loperamide hydrochloride, and Experiment 3 used 6 mg/kg morphine sulfate. On the following test day, half of the animals received the opposite treatment, resulting in four conditioning manipulations: Drug/Drug, Drug/Vehicle, Vehicle/Drug, and Vehicle/Vehicle. Nociceptive thresholds were assessed with the mechanical paw withdrawal threshold test each day following the conditioning procedure. In all three experiments, no significant differences were detected on test day between control and placebo groups, indicating a lack of a conditioned placebo analgesic response. Our results contrast with prior research that implies the existence of a reliable and robust response to placebo treatment. We conclude that placebo analgesia in rats is not particularly robust and that it is difficult to achieve using conventional procedures and proper experimental design.
    Pain 07/2014; 155(10). DOI:10.1016/j.pain.2014.07.004 · 5.84 Impact Factor


Available from
Jul 28, 2014